A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine Samples
Open Access
- 1 March 2018
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 38 (3) , 1471-1477
Abstract
Background/Aim: Prostate cancer (PCa) diagnosis using patient urine samples represents a non-invasive and more convenient method than the conventional biopsy and prostate-specific antigen (PSA) test. This study intended to identify a biomarker panel to distinguish PCa from benign prostate using urine samples. Materials and Methods: We identified six biomarkers with differential gene expression in 154 PCa and benign prostate specimens. We then determined mRNA expression signature and the diagnostic performance of the 6-biomarker panel in 156 urine samples from patients with PCa and benign disease. Results: The 6-biomarker panel distinguished PCa from benign prostate cases with sensitivity of 80.6%, specificity of 62.9% and area under the curve (AUC) of 0.803 (p<0.0001), whereas serum PSA at 4 ng/ml cutoff had sensitivity of 95.5%, specificity of 20.2% and AUC of 0.521 (p<0.0001). Conclusion: The 6-biomarker panel for use in urine samples was able to distinguish PCa from benign prostate with higher specificity and accuracy than PSA and may be useful in clinical settings.Keywords
This publication has 18 references indexed in Scilit:
- Use of two gene panels for prostate cancer diagnosis and patient risk stratificationTumor Biology, 2016
- Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve MenJournal of Urology, 2015
- Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy DecisionsJournal of Urology, 2011
- PSA screening — a review of recent studiesEuropean Journal of Cancer, 2009
- Urine markers in monitoring for prostate cancerProstate Cancer and Prostatic Diseases, 2009
- Detection of Early Prostate Cancer Using a Hepsin-Targeted Imaging AgentCancer Research, 2008
- A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate CancerCancer Research, 2008
- Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate CancerClinical Cancer Research, 2007
- Impact of differential cyclin D1 expression and localisation in prostate cancerBritish Journal of Cancer, 2007
- Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic CurvesJournal of Urology, 1994